Stryker Corp
SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3020% below fair value
$306.81+14.95 (+5.12%)
Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –
Stryker Vascular by Year
Vascular (Neurovascular Ischemic/Hemorrhagic Stroke & Inari Peripheral Vascular) — U.S. Net Sales ($M) ($M)
Stryker Vascular: $1,048M in FY2025, up 107.1% from a year earlier.
Latest, FY2025
1,048
Period ended Dec 31, 2025
Change on a year earlier
+107.1%
506 in FY2024
History
7 years
Since FY2019
Sources
3
Documents cited below
Where the FY2025 figure comes from
Reported in Stryker Form 8-K Supplemental Sales Schedules, Recast 8-K & Form 10-K/10-Q Note 15.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Vascular (Neurovascular Ischemic/Hemorrhagic Stroke & Inari Peripheral Vascular) — U.S. Net Sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1,048 | +107.1% | 0000310764-26-000041|syk-20260626_d2.htm ↗ |
| FY2024 | Dec 31, 2024 | 506 | +4.8% | 0000310764-26-000041|syk-20260626_d2.htm ↗ |
| FY2023 | Dec 31, 2023 | 483 | +8.3% | 0000310764-26-000041|syk-20260626_d2.htm ↗ |
| FY2022 | Dec 31, 2022 | 446 | -1.1% | 0000310764-23-000017|syk-20221231.htm ↗ |
| FY2021 | Dec 31, 2021 | 451 | +18.4% | 0000310764-22-000028|syk-20211231.htm ↗ |
| FY2020 | Dec 31, 2020 | 381 | -2.6% | 0000310764-22-000028|syk-20211231.htm ↗ |
| FY2019 | Dec 31, 2019 | 391 | – | 0000310764-22-000028|syk-20211231.htm ↗ |
Breakdown
What makes up vascular
Cite this data
StockData. (2026). Stryker Vascular ($M), annual FY2019–FY2025 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/fran-vasc-us-rev
See every metric in the Stryker KPI table. Data updated Nov 2, 2026.